Riskpilot← Back to searchSign inGet full accessVasa Tandvård i Linköping AB
ABActiveOrg 5591582266Thorells Gata 12Dental practice care activities · NACE 8623Est. 20182 employees
Revenue 2025
SEK 1,4M
-56% vs 2024
EBITDA margin
4.8%
-94% vs 2024
Equity ratio
35.8%
Financial strength
Net profit 2025
SEK 36K
-94% vs 2024
| Revenue | SEK 1,4M | -56% |
| EBITDA | SEK 68K | -94% |
| Net profit | SEK 36K | -94% |
| Total assets | SEK 2M | -37% |
| Equity | SEK 722K | +5% |
| Employees | 2 | — |
Legal name
Vasa Tandvård i Linköping AB
Org number
5591582266
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
7 maj 2018
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är tandvård och därmed förenlig verksamhet.
Address
Thorells Gata 12
Email
moazezz@dr.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 962 | 6 559 | 5 261 | 3 257 | 1 417 |
| Staff expenses | — | — | −1 970 | −899 | −196 |
| EBITDA | 1 070 | 751 | 1 745 | 1 214 | 68 |
| Depreciation & amort. | −244 | −256 | −343 | −359 | −125 |
| EBIT | 826 | 495 | 1 402 | 855 | −57 |
| Net financials | — | −5 | −34 | −23 | 18 |
| Profit before tax | 545 | 226 | 1 060 | 730 | 55 |
| Tax | −119 | −193 | −162 | −163 | −18 |
| Net profit | 426 | 33 | 898 | 567 | 36 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 430 | 1 961 | 3 546 | 3 202 | 2 019 |
| Equity | 1 189 | 121 | 1 019 | 686 | 722 |
| Long-term debt | 0 | 0 | 240 | 0 | — |
| Short-term debt | 1 051 | 565 | 780 | 1 301 | 181 |
| Total debt | 1 051 | 565 | 1 020 | 1 301 | 181 |
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
20212025
Equity ratio
35.8%
This company
38.2%
Market median
+6% vs market
20212025
Return on equity
5.0%
This company
18.4%
Market median
-73% vs market
20212025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20212025
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20212025
Debt / equity
1.79×
This company
0.62×
Market median
-189% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
CG Chief Auditor | Chief Auditor | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rimforsa Munhälsocentrum AB
Vasa Tandvård i Linköping AB Board members of Vasa Tandvård i Linköping AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl-Johan Georg Sandberg | Chief Auditor | 0 companies |
| Ali Akbar Tamali | Board of Directors | 0 companies |
| Nazanin Sadat Moazzez | Deputy Board Member | 0 companies |
| Seyed Alireza Moazzez | Chairman | 0 companies |
| Robin Moazzez | Board of Directors | 0 companies |